Genus (LON:GNS) Earns Not Rated Rating from Shore Capital

Genus (LON:GNS)‘s stock had its “not rated” rating restated by equities researchers at Shore Capital in a research report issued to clients and investors on Friday, Marketbeat reports.

Genus Stock Up 4.5 %

GNS stock opened at GBX 1,718 ($21.54) on Friday. The company has a market cap of £1.13 billion, a price-to-earnings ratio of 14,316.67, a P/E/G ratio of 2.87 and a beta of 0.37. The company has a debt-to-equity ratio of 53.54, a quick ratio of 1.08 and a current ratio of 1.80. The business’s 50-day moving average is GBX 1,955.79 and its two-hundred day moving average is GBX 1,837.12. Genus has a fifty-two week low of GBX 1,478 ($18.53) and a fifty-two week high of GBX 2,378 ($29.81).

Insider Buying and Selling at Genus

In other news, insider Jorgen Kokke sold 2,186 shares of Genus stock in a transaction dated Monday, September 16th. The stock was sold at an average price of GBX 1,956 ($24.52), for a total transaction of £42,758.16 ($53,601.81). Also, insider Iain Ferguson acquired 3,000 shares of the business’s stock in a transaction that occurred on Thursday, September 5th. The shares were bought at an average price of GBX 1,800 ($22.56) per share, with a total value of £54,000 ($67,694.62). 0.75% of the stock is owned by corporate insiders.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.